MILAN (Reuters) – Italian diagnostics group DiaSorin received on Tuesday approval from Canadian authorities to sell its COVID-19 antibody tests but will not supply its testing kits to the Italian government, Chief Executive Carlo Rosa said on Wednesday.
“The Italian government decided to go in a different direction, with Abbott(Laboratories)…we are going to provide tests to many countries but not to ours,” Rosa said in a call with analysts.
The Chief Executive added that the sale of coronavirus swab tests would increase the group’s monthly revenues by 10-12 million euros($11-13 million), up from the 5-10 million euros initially forecast by the diagnostics group.
Reporting by Giancarlo Navach, editing by Giulia Segreti
Our Standards:The Thomson Reuters Trust Principles.
Subscribe to our Newsletter and get the complete health program for a health you.